Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
2019 · Journal of Hepatology · 346 citations
https://doi.org/10.1016/j.jhep.2019.11.003
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
558
Citations
4
h-index
3
i10-index
Stephanie Buchholz is an academic researcher from Federal Institute for Drugs and Medical Devices. The author has contributed to research in topics: Hepatitis C virus research & Hepatitis B Virus Studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 4, co-authored 11 publications.
ORCID: 0009-0007-8750-9684Click to start Chat